To view a copy of this licence, visit About this article Cite this article Overgaard, R.V., Navarria, A., Ingwersen, S.H
The ATTAIN Program: Obesity Trials The ATTAIN (Assessment of orforglipron Treatment for Adiposity and Its Impact on body weight reduction) program comprises multiple Phase 3 trials designed to evaluate orforglipron in various obesity-related populations and clinical scenarios
79 In observational studies, those with the highest dietary magnesium intake reported better sleep quality, including less snoring and less daytime sleepiness
Maintains firmness, elasticity, and hydration for a youthful complexion
The free Pivot app adds practical utility that most platforms skip entirely
not for safety or efficacy guidance